Clinical trial
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving…
NCT00332553 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00332553 |
|---|---|
| Title | Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen |
| Official title | Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vasomotor Symptoms, Endometrial Safety |
| Intervention type | Drug |
| Interventions | Raloxifene, medroxyprogesterone acetate, estrogen, 17 beta estradiol |
| Enrollment | 150 |
| Start date | Feb 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Jun 1, 2006 |
| Last update posted | May 15, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: